Impact of left ventricular dyssynchrony by phase analysis on cardiovascular outcomes in patients with end-stage renal disease

被引:54
作者
AlJaroudi, Wael [1 ]
Aggarwal, Himanshu [1 ]
Venkataraman, Rajesh [1 ]
Heo, Jaekyeong [1 ]
Iskandrian, Ami E. [1 ]
Hage, Fadi G. [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA
[2] Birmingham Vet Affairs Med Ctr, Div Cardiol, Birmingham, AL USA
关键词
Dyssynchrony; phase analysis; end-stage renal disease; left ventricular ejection fraction (LVEF); coronary artery disease (CAD); MECHANICAL DYSSYNCHRONY; PERFUSION;
D O I
10.1007/s12350-010-9271-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease is the leading cause of mortality in patients with end-stage renal disease (ESRD). While left ventricular (LV) perfusion pattern and ejection fraction (EF) are important determinant of outcome, the prognostic importance of LV dyssynchrony, which can also be assessed by gated SPECT myocardial perfusion imaging (MPI), has not been well studied in this population. The indices of LV mechanical dyssynchrony were measured by automated analysis of gated SPECT MPI in patients with ESRD who were evaluated for transplantation at our institution (2001-2004) and who had coronary angiography within 6 months of the evaluation. All-cause mortality data were prospectively collected and verified against the social security death index database. The study population consisted of 144 ESRD patients aged 53 +/- A 9 years. 35% were women and 63% had diabetes mellitus. The LVEF was 48 +/- A 12%. They were followed-up for 41 +/- A 28 months during which time 55 (38%) died prior to renal transplantation. An abnormal QRS duration was not predictive of worse outcomes (log-rank P = .9). The median phase bandwidth (BW) was 62A degrees (inter-quartile range 47-98A degrees) and standard deviation (SD) was 23A degrees (inter-quartile range 15-35A degrees). Patients with a BW above the median had worse survival (log-rank P = .017) and there was a trend toward worse survival in those with a SD above the median (log-rank P = .096). A 2-year mortality was higher in those with BW a parts per thousand yen 62A degrees in the entire cohort, and in the subsets of patients with normal LVEF (log-rank P = .001), coronary artery disease by angiography, increased LV mass index, QRS < 110 ms, and perfusion defect size < 20% of the LV. LV mechanical dyssynchrony by phase analysis is a predictor of mortality in patients with ESRD. It may have a role in risk-stratifying patients and should be incorporated in future studies using gated MPI.
引用
收藏
页码:1058 / 1064
页数:7
相关论文
共 50 条
  • [41] The effects of mineralocorticoid receptor antagonists on cardiovascular outcomes in patients with end-stage renal disease and heart failure
    Lin, Donna Shu-Han
    Lin, Fang-Ju
    Lin, Yu-Sheng
    Lee, Jen-Kuang
    Lin, Yen-Hung
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (01) : 98 - 107
  • [42] Outcomes of Dialysis Among Patients With End-Stage Renal Disease (ESRD)
    Ejaz, Ayesha
    Junejo, Abdul Manan
    Ali, Muhammad
    Ashfaq, Ahsan
    Hafeez, Abdul Rauf
    Khan, Sadaqat Ali
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [43] Renal ablation in patients with end-stage renal disease
    Hansch, A.
    Pfeil, A.
    Neumann, R.
    Neumann, S.
    Mayer, T. E.
    Wolf, G.
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2011, 40 (04) : 308 - 314
  • [44] Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease
    Walther, Carl P.
    Niu, Jingbo
    Winkelmayer, Wolfgang C.
    Cheema, Faisal H.
    Nair, Ajith P.
    Morgan, Jeffrey A.
    Fedson, Savitri E.
    Deswal, Anita
    Navaneethan, Sankar D.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (14):
  • [45] Effect of Peritoneal Dialysis Treatment on Left Ventricular Systolic and Diastolic Functions in Patients with End-Stage Renal Disease
    Kavuncuoglu, Feridun
    Unal, Aydin
    Yarlioglues, Mikail
    Duran, Mustafa
    Kocyigit, Ismail
    Akcakaya, Mesut
    Oguzhan, Nilfer
    Cilan, Havva
    Sipahioglu, Murat Hayri
    Tokgoz, Bulent
    Oymak, Oktay
    Utas, Cengiz
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2014, 23 (03): : 202 - 209
  • [46] Assessment of Left Ventricular Dissipative Energy Loss by Vector Flow Mapping in Patients With End-Stage Renal Disease
    Zhong, Yue
    Liu, Yanting
    Wu, Ting
    Song, Huizi
    Chen, Zhongxiu
    Zhu, Wei
    Cai, Yuyan
    Zhang, Wen
    Bai, Wenjuan
    Tang, Hong
    Rao, Li
    JOURNAL OF ULTRASOUND IN MEDICINE, 2016, 35 (05) : 965 - 973
  • [47] The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease
    Wang, Xiaoyan
    Chen, Xiaohui
    Tang, Yuting
    Zhang, Liuping
    Wang, Yue
    Hou, Zhenghua
    Jang, Wenhao
    Yuan, Yonggui
    FRONTIERS IN NEUROSCIENCE, 2023, 16
  • [48] Left Atrial Dysfunction in End-Stage Renal Disease Patients Treated by Hemodialysis
    Malik, Jan
    Lachmanova, Jana
    Kudlicka, Jaroslav
    Rocinova, Katarina
    Valerianova, Anna
    Bartkova, Magdalena
    Tesar, Vladimir
    NEPHRON, 2016, 133 (03) : 169 - 174
  • [49] Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?
    Roumeliotis, Stefanos
    Roumeliotis, Athanasios
    Dounousi, Evangelia
    Eleftheriadis, Theodoros
    Liakopoulos, Vassilios
    CURRENT VASCULAR PHARMACOLOGY, 2021, 19 (01) : 77 - 90
  • [50] Hyperhomocysteinemia and end-stage renal disease: Determinants and association with cardiovascular disease in Tunisian patients
    Fellah, H
    Feki, M
    Hsairi, M
    Sanhaji, H
    Kaabachi, N
    Ben Abdallah, T
    Massy, ZA
    Ben Maiz, H
    Lacour, B
    Mebazaa, A
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (05) : 675 - 680